血液系统恶性肿瘤的临床试验
总计4788个结果
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)招聘中
-
University Hospital Ostrava完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer Center撤销局部晚期恶性实体瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 骨转移性恶性肿瘤
-
Zhejiang UniversityYake Biotechnology Ltd.尚未招聘
-
University Hospital of Cologne招聘中
-
Assistance Publique - Hôpitaux de Paris尚未招聘活动性恶性肿瘤 | 恶性肿瘤或其治疗的危及生命的并发症
-
All India Institute of Medical Sciences, New Delhi未知
-
Asan Medical Center未知单倍相合造血干细胞移植 | 恶性疾病 | 非恶性疾病大韩民国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
University Hospital of CologneRadboud University Medical Center完全的
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)暂停
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer Center终止
-
Heidelberg University未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中晚期恶性实体瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤美国
-
Esanex Inc.National Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer Center尚未招聘
-
M.D. Anderson Cancer CenterNational Institute of Nursing Research (NINR)主动,不招人
-
Institut de Cancérologie de la Loire完全的
-
National Cancer Institute (NCI)主动,不招人
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
Lucid Lane, IncM.D. Anderson Cancer Center招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteReliable Cancer Therapies终止
-
Centre Hospitalier Universitaire de BesanconEtablissement Français du Sang; Bellicum Pharmaceuticals未知
-
Sameek RoychowdhuryNational Cancer Institute (NCI)撤销局部晚期恶性实体瘤 | 转移性恶性实体瘤 | ALK基因突变 | 脑转移性恶性肿瘤 | 晚期恶性肿瘤 | ALK融合蛋白表达 | 中枢神经系统转移性恶性肿瘤 | ROS1基因突变 | ALK基因扩增 | ROS1融合阳性 | ROS1 基因扩增美国
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Mayo Clinic终止
-
Boston Children's HospitalFDA Office of Orphan Products Development主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Memorial Sloan Kettering Cancer Center完全的
-
Fondazione del Piemonte per l'Oncologia未知
-
Luzerner Kantonsspital招聘中
-
University of ChicagoNational Cancer Institute (NCI)完全的
-
Mundipharma Research GmbH & Co KG完全的